Phospholipase C gamma 1 (PLCG1) R707Q mutation is counterselected under targeted therapy in a patient with hepatic angiosarcoma.
about
Phospholipase C gamma 1 (PLCG1) R707Q mutation is counterselected under targeted therapy in a patient with hepatic angiosarcoma.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Phospholipase C gamma 1 (PLCG1 ...... ent with hepatic angiosarcoma.
@ast
Phospholipase C gamma 1 (PLCG1 ...... ent with hepatic angiosarcoma.
@en
type
label
Phospholipase C gamma 1 (PLCG1 ...... ent with hepatic angiosarcoma.
@ast
Phospholipase C gamma 1 (PLCG1 ...... ent with hepatic angiosarcoma.
@en
prefLabel
Phospholipase C gamma 1 (PLCG1 ...... ent with hepatic angiosarcoma.
@ast
Phospholipase C gamma 1 (PLCG1 ...... ent with hepatic angiosarcoma.
@en
P2860
P50
P356
P1433
P1476
Phospholipase C gamma 1 (PLCG1 ...... ent with hepatic angiosarcoma.
@en
P2093
Dominiek Smeets
P2860
P304
36418-36425
P356
10.18632/ONCOTARGET.5503
P407
P577
2015-10-10T00:00:00Z